Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $131.0M | $218.5M | $305.7M | $389.2M | $624.8M | $789.0M | $813.9M | $688.0M | $646.8M | $531.3M | $513.5M | $554.6M | $604.4M | $633.0M | $669.7M | $805.3M | $886.2M | $980.8M | $962.8M | $990.9M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Amedisys, Inc.'s last 12-month Gross Profit is $928.5M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Amedisys, Inc.'s Gross Profit growth was (5.9%). The average annual Gross Profit growth rates for Amedisys, Inc. have been 0.3% over the past three years, 3.8% over the past five years.
Over the last year, Amedisys, Inc.'s Gross Profit growth was (5.9%), which is lower than industry growth of 0.1%. It indicates that Amedisys, Inc.'s Gross Profit growth is Bad.